Andras Rab M.D.
Dr. Rab received his M.D. degree from the University of Pecs, Hungary in 2000. He completed post-doctoral studies in protein trafficking related to Cystic Fibrosis at Department of Cell Biology at University of Alabama at Birmingham, United States, from 2002 to 2006. From 2000 to 2008 - with an interruption by research at Birmingham- he was completed Laboratory Medicine residency program at University of Pecs and received Hungarian Board certificate from Laboratory Medicine in 2008. In 2010 he returned to University of Alabama at Birmingham where he continued his research on Cystic fibrosis. Dr. Rab joined Dr. Eric Sorscher laboratory at University of Alabama at Birmingham in 2006 and participated to establish a Fischer Rat Thyroid model system with expression of clinically relevant CFTR mutations. Since then, these cell lines have been distributed to numerous laboratories in the Cystic Fibrosis Research community, including the Pharmaceutical Industry. Up to this date, he continued to study in vitro functional correction of rare CFTR variants by small molecule modulators (Theratyping). He is the author/co-author of 17 scientific articles and book chapters.